Transforming growth factor-β1 regulates Cdk5 activity in primary sensory neurons

Journal of Biological Chemistry

Volumn 287, Issue 20, 2012, Pages 16917-16929

  Utreras, Elias ^a   Keller, Jason ^b   Terse, Anita ^a   Prochazkova, Michaela ^a   Iadarola, Michael J ^b   Kulkarni, Ashok B ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DEVELOPMENT; DORSAL ROOT GANGLIA; HYPERALGESIA; INFLAMMATORY PROCESS; KNOCK OUTS; NEUROBLASTOMA CELLS; PROTEIN LEVEL; SENSORY NEURONS; TRANSFORMING GROWTH FACTORS; TRANSIENT RECEPTOR POTENTIAL VANILLOID;

CROSSTALK; MAMMALS; PHOSPHORYLATION; SODIUM;

NEURONS;

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYCLIN DEPENDENT KINASE 5; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN P35; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; HYPERALGESIA; IMMUNOREGULATION; INFLAMMATION; MOLECULAR INTERACTION; MOUSE; NEUROBLASTOMA; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SPINAL GANGLION; THERMAL STIMULATION; TRIGEMINUS GANGLION; WESTERN BLOTTING;

ANIMALS; CALCIUM; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 5; GANGLIA, SPINAL; HYPERALGESIA; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 3; PAIN; PHOSPHORYLATION; RATS; SENSORY RECEPTOR CELLS; TRANSFORMING GROWTH FACTOR BETA1; TRIGEMINAL GANGLION; TRPV CATION CHANNELS;

MUS; RATTUS;

EID: 84860874746     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.329979     Document Type: Article

References (50)

1. Dhavan, R., and Tsai, L. H. (2001) A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2, 749-759 (Pubitemid 33679837)
2. Dhariwala, F. A., and Rajadhyaksha, M. S. (2008) An unusual member of the Cdk family, Cdk5. Cell. Mol. Neurobiol. 28, 351-369
3. Ohshima, T., Ward, J. M., Huh, C. G., Longenecker, G., Veeranna, Pant, H. C., Brady, R. O., Martin, L. J., and Kulkarni, A. B. (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl. Acad. Sci. U.S.A. 93, 11173-11178 (Pubitemid 26333137)
4. Ko, J., Humbert, S., Bronson, R. T., Takahashi, S., Kulkarni, A. B., Li, E., and Tsai, L. H. (2001) p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J. Neurosci. 21, 6758-6771 (Pubitemid 32781119)
5. Tanaka, T., Veeranna, Ohshima, T., Rajan, P., Amin, N. D., Cho, A., Sreenath, T., Pant, H. C., Brady, R. O., and Kulkarni, A. B. (2001) Neuronal cyclin-dependent kinase 5 activity is critical for survival. J. Neurosci. 21, 550-558
6. Li, B. S., Zhang, L., Takahashi, S., Ma, W., Jaffe, H., Kulkarni, A. B., and Pant, H. C. (2002) Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J. 21, 324-333 (Pubitemid 34137294)
7. Pareek, T. K., Keller, J., Kesavapany, S., Pant, H. C., Iadarola, M. J., Brady, R. O., and Kulkarni, A. B. (2006) Cyclin-dependent kinase 5 activity regulates pain signaling. Proc. Natl. Acad. Sci. U.S.A. 103, 791-796 (Pubitemid 43153104)
8. Yang, Y. R., He, Y., Zhang, Y., Li, Y., Li, Y., Han, Y., Zhu, H., and Wang, Y. (2007) Activation of cyclin-dependent kinase 5 (Cdk5) in primary sensory and dorsal horn neurons by peripheral inflammation contributes to heat hyperalgesia. Pain 127, 109-120 (Pubitemid 44959433)
9. Pareek, T. K., and Kulkarni, A. B. (2006) Cdk5, a new player in pain signaling. Cell Cycle 5, 585-588
10. Pareek, T. K., Keller, J., Kesavapany, S., Agarwal, N., Kuner, R., Pant, H. C., Iadarola, M. J., Brady, R. O., and Kulkarni, A. B. (2007) Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1. Proc. Natl. Acad. Sci. U.S.A. 104, 660-665 (Pubitemid 46123081)
11. Utreras, E., Futatsugi, A., Rudrabhatla, P., Keller, J., Iadarola, M. J., Pant, H. C., and Kulkarni, A. B. (2009) Tumor necrosis factor-α regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35. J. Biol. Chem. 284, 2275-2284
12. Utreras, E., Futatsugi, A., Pareek, T. K., and Kulkarni, A. B. (2009) Molecular roles of Cdk5 in pain signaling. Drug Discov. Today Ther. Strateg. 6, 105-111
13. Utreras, E., Terse, A., Keller, J., Iadarola, M. J., and Kulkarni, A. B. (2011) Resveratrol inhibits Cdk5 activity through regulation of p35 expression. Mol. Pain 7, 49
14. Xie, W. Y., He, Y., Yang, Y. R., Li, Y. F., Kang, K., Xing, B. M., and Wang, Y. (2009) Disruption of Cdk5-associated phosphorylation of residue threonine 161 of the δ-opioid receptor. Impaired receptor function and attenuated morphine antinociceptive tolerance. J. Neurosci. 29, 3551-3564
15. Massagué, J. (1990) The transforming growth factor-β family. Annu. Rev. Cell Biol. 6, 597-641
16. Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., and Calvin, D. (1992) Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693-699
17. Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., and Karlsson, S. (1993) Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U.S.A. 90, 770-774 (Pubitemid 23028947)
18. Kulkarni, A. B., Ward, J. M., Yaswen, L., Mackall, C. L., Bauer, S. R., Huh, C. G., Gress, R. E., and Karlsson, S. (1995) Transforming growth factor-β1 null mice. An animal model for inflammatory disorders. Am. J. Pathol. 146, 264-275
19. Wyss-Coray, T. (2006) TGF-β pathway as a potential target in neurodegeneration and Alzheimer. Curr. Alzheimer Res. 3, 191-195
20. Brionne, T. C., Tesseur, I., Masliah, E., and Wyss-Coray, T. (2003) Loss of TGF-β1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40, 1133-1145 (Pubitemid 38032790)
21. Makwana, M., Jones, L. L., Cuthill, D., Heuer, H., Bohatschek, M., Hristova, M., Friedrichsen, S., Ormsby, I., Bueringer, D., Koppius, A., Bauer, K., Doetschman, T., and Raivich, G. (2007) Endogenous transforming growth factor β1 suppresses inflammation and promotes survival in adult CNS. J. Neurosci. 27, 11201-11213 (Pubitemid 47621324)
22. Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J. V., Lin, A. H., Crews, L., Tremblay, P., Mathews, P., Mucke, L., Masliah, E., and Wyss- Coray, T. (2006) Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer pathology. J. Clin. Invest. 116, 3060-3069 (Pubitemid 44684491)
23. Grammas, P., and Ovase, R. (2002) Cerebrovascular transforming growth factor-β contributes to inflammation in the Alzheimer disease brain. Am. J. Pathol. 160, 1583-1587 (Pubitemid 34525638)
24. Wyss-Coray, T., Feng, L., Masliah, E., Ruppe, M. D., Lee, H. S., Toggas, S. M., Rockenstein, E. M., and Mucke, L. (1995) Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1. Am. J. Pathol. 147, 53-67
25. Ishizaki, K., Takeshima, T., Fukuhara, Y., Araki, H., Nakaso, K., Kusumi, M., and Nakashima, K. (2005) Increased plasma transforming growth factor- β1 in migraine. Headache 45, 1224-1228 (Pubitemid 350004912)
26. Echeverry, S., Shi, X. Q., Haw, A., Liu, H., Zhang, Z. W., and Zhang, J. (2009) Transforming growth factor-β1 impairs neuropathic pain through pleiotropic effects. Mol. Pain 5, 16
27. Tramullas, M., Lantero, A., Díaz, A., Morchón, N., Merino, D., Villar, A., Buscher, D., Merino, R., Hurlé, J. M., Izpisúa-Belmonte, J. C., and Hurlé, M. A. (2010) BAMBI (bone morphogenetic protein and activin membrane- bound inhibitor) reveals the involvement of the transforming growth factor-β family in pain modulation. J. Neurosci. 30, 1502-1511
28. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450
29. Kulkarni, A. B., and Karlsson, S. (1993) Transforming growth factor-β1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am. J. Pathol. 143, 3-9 (Pubitemid 24058154)
30. Larsson, J., Goumans, M. J., Sjöstrand, L. J., van Rooijen, M. A., Ward, D., Levéen, P., Xu, X., ten Dijke, P., Mummery, C. L., and Karlsson, S. (2001) Abnormal angiogenesis but intact hematopoietic potential in TGF-β type I receptor-deficient mice. EMBO J. 20, 1663-1673 (Pubitemid 32299403)
31. Agarwal, N., Offermanns, S., and Kuner, R. (2004) Conditional gene deletion in primary nociceptive neurons of trigeminal ganglia and dorsal root ganglia. Genesis 38, 122-129 (Pubitemid 38506849)
32. Cuellar, J. M., Manering, N. A., Klukinov, M., Nemenov, M. I., and Yeomans, D. C. (2010) Thermal nociceptive properties of trigeminal afferent neurons in rats. Mol. Pain 6, 39
33. Mitchell, K., Bates, B. D., Keller, J. M., Lopez, M., Scholl, L., Navarro, J., Madian, N., Haspel, G., Nemenov, M. I., and Iadarola, M. J. (2010) Ablation of rat TRPV1-expressing Aδ/C-fibers with resiniferatoxin. Analysis of withdrawal behaviors, recovery of function and molecular correlates. Mol. Pain 6, 94
34. Iadarola, M. J., Brady, L. S., Draisci, G., and Dubner, R. (1988) Enhancement of dynorphin gene expression in spinal cord following experimental inflammation. Stimulus specificity, behavioral parameters, and opioid receptor binding. Pain 35, 313-326 (Pubitemid 19010487)
35. Fan, R. J., Shyu, B. C., and Hsiao, S. (1995) Analysis of nocifensive behavior induced in rats by CO2 laser pulse stimulation. Physiol. Behav. 57, 1131-1137
36. Takahashi, S., Ohshima, T., Cho, A., Sreenath, T., Iadarola, M. J., Pant, H. C., Kim, Y., Nairn, A. C., Brady, R. O., Greengard, P., and Kulkarni, A. B. (2005) Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc. Natl. Acad. Sci. U.S.A. 102, 1737-1742 (Pubitemid 40209237)
37. Lutz, M., Krieglstein, K., Schmitt, S., ten Dijke, P., Sebald, W., Wizenmann, A., and Knaus, P. (2004) Nerve growth factor mediates activation of the Smad pathway in PC12 cells. Eur. J. Biochem. 271, 920-931 (Pubitemid 38299646)
38. Luo, J., and Miller, M. W. (1999) Transforming growth factor β1-regulated cell proliferation and expression of neural cell adhesion molecule in B104 neuroblastoma cells. Differential effects of ethanol. J. Neurochem. 72, 2286-2293 (Pubitemid 29242178)
39. Miller, M. W., Mooney, S. M., and Middleton, F. A. (2006) Transforming growth factor β1 and ethanol affect transcription and translation of genes and proteins for cell adhesion molecules in B104 neuroblastoma cells. J. Neurochem. 97, 1182-1190
40. Bottenstein, J. E., and Sato, G. H. (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. U.S.A. 76, 514-517 (Pubitemid 9106659)
41. Harada, T., Morooka, T., Ogawa, S., and Nishida, E. (2001) ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat. Cell Biol. 3, 453-459 (Pubitemid 32422080)
42. Kulkarni, A. B., Thyagarajan, T., and Letterio, J. J. (2002) Function of cytokines within the TGF-β superfamily as determined from transgenic and gene knockout studies in mice. Curr Mol. Med. 2, 303-327 (Pubitemid 34649849)
43. Wahl, S. M., and Chen, W. (2005) Transforming growth factor-β- induced regulatory T cells referee inflammatory and autoimmune diseases. Arthritis Res. Ther. 7, 62-68 (Pubitemid 40439440)
44. Ronaldson, P. T., Finch, J. D., Demarco, K. M., Quigley, C. E., and Davis, T. P. (2011) Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier. J. Pharmacol. Exp. Ther. 336, 827-839
45. Ronaldson, P. T., Demarco, K. M., Sanchez-Covarrubias, L., Solinsky, C. M., and Davis, T. P. (2009) Transforming growth factor-β signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain. J. Cereb. Blood Flow Metab. 29, 1084-1098
46. Bø, S. H., Davidsen, E. M., Gulbrandsen, P., Dietrichs, E., Bovim, G., Stovner, L. J., and White, L. R. (2009) Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia 29, 365-372
47. Habashi, J. P., Doyle, J. J., Holm, T. M., Aziz, H., Schoenhoff, F., Bedja, D., Chen, Y., Modiri, A. N., Judge, D. P., and Dietz, H. C. (2011) Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332, 361-365
48. Pagel, J. I., and Deindl, E. (2011) Early growth response 1, a transcription factor in the cross-fire of signal transduction cascades. Indian J. Biochem. Biophys. 48, 226-235
49. Xu, P., Van Slambrouck, C., Berti-Mattera, L., and Hall, A. K. (2005) Activin induces tactile allodynia and increases calcitonin gene-related peptide after peripheral inflammation. J. Neurosci. 25, 9227-9235 (Pubitemid 41500831)
50. Zhu, W., Xu, P., Cuascut, F. X., Hall, A. K., and Oxford, G. S. (2007) Activin acutely sensitizes dorsal root ganglion neurons and induces hyperalgesia via PKC-mediated potentiation of transient receptor potential vanilloid I. J. Neurosci. 27, 13770-13780 (Pubitemid 350278254)